Improvement in Circulatory and Oxygenation Status by Perflubron Emulsion (Oxygent™ HT) in a Canine Model of Surgical Hemodilution

References

• Goodnough L T, Shuck J M. Risk, options and informed consent for blood transfusion in elective surgery. Am J Surg 1990; 159: 602–9
   PubMed Web of Science ®Google Scholar
• Sazama K. Reports of 355 transfusion-associated deaths: 1976–1985. Transfusion 1990; 30: 583–90
   PubMed Web of Science ®Google Scholar
• Von Fieldner V, Higby D J, Kim U. Graft-versus-host reactions following blood product transfusion. Am J Med 1982; 72: 951–61
   PubMed Web of Science ®Google Scholar
• Thaler M, Shamiss A, Orgad S. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery. N Engl J Med 1989; 321: 25–8
   PubMed Web of Science ®Google Scholar
• Magart M, Stewart S. The mechanism and management of noncardiogenic edema following cardiopulmonary bypass. Ann Thor Surg 1987; 43: 231–6
   PubMed Web of Science ®Google Scholar
• Schriemer P A, Longnecker D E, Mintz P D. The possible immunosuppressive effects of perioperative blood transfusion in cancer patients. Anesthesiology 1988; 68: 422–8
   PubMed Web of Science ®Google Scholar
• Nyberg S L, Cerra F B. Treatment of severe anemia with perfluorocarbon blood substitutes: a clinical overview. Clin Intensive Care 1991; 4: 226–32
   Google Scholar
• Toy P Tcy, Strauss R G, Stehling L G. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med 1987; 316: 517–20
   PubMed Web of Science ®Google Scholar
• Mann M, Sacks H G, Goldfinger D. Safety of autologous blood donation prior to elective surgery for a variety of potentially “high-risk” patients. Transfusion 1983; 23: 229–32
   PubMed Web of Science ®Google Scholar
• Owings D V, Kruskall M S, Thurer R L, Donovan L M. Autologous blood donation prior to elective cardiac surgery; safety and effect on subsequent blood loss. JAMA 1989; 262: 1963–68
   PubMed Web of Science ®Google Scholar
• DelRossi AJ, Cernaianu A C, Vertrees R A. Platelet-rich plasma reduces postoperative blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 100: 281–86
   PubMed Web of Science ®Google Scholar
• Clemens D H, Sculco T P, Burje S W, Mayer K, Levine D B. Salvage and reinfusion of postoperative sanguineous wound drainage. J Bone Joint Surg 1992; 74A: 646
   Web of Science ®Google Scholar
• Messmer K, Kreimeier U, Intaglietta M. Present state of intentional hemodilution. Eur Surg Res 1986; 18: 254
   PubMed Web of Science ®Google Scholar
• DelRossi AJ, Cernaianu A C, Botros S, Lemole G M. Prophylactic treatment of postperfusion bleeding with EACA. Chest 1989; 96: 27–30
   PubMed Web of Science ®Google Scholar
• Czer L S, Bateman T M, Gray R J. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass; reduction of blood products usage with desmopressin. J Am Coll Cardiol 1987; 9: 1139–47
   PubMed Web of Science ®Google Scholar
• Bidstrup B P, Royston D, Sapford R N, Taylor K M. Reduction of blood loss and blood use after cardiopulmonary bypass with high dose aprotinine (Trasylol). J Thorac Cardiovasc Surg 1989; 97: 364–72
   PubMed Web of Science ®Google Scholar
• Vedrinne C, Girard C, Jegaden O. Reduction of blood loss and blood use after cardiopulmonary bypass with high dose aprotinine versus autologous fresh whole blood transfusion. J Cardiothorac Vasc Anesth 1992; 6: 319–23
   PubMedGoogle Scholar
• Tremper K K, Friedman E M, Levine R, Lapin D, Camarillo D. The perioperative treatment of severely anemic patients with perfluorochemical oxygen transport fluid, Fluosol-DA. N Engl J Med 1982; 307: 277–83
   PubMed Web of Science ®Google Scholar
• Foulke G E, Harlow D J. Effective measures for reducing blood loss from diagnostic laboratory tests in the intensive care unit patients. Crit Care Med 1989; 17: 1143–5
   PubMed Web of Science ®Google Scholar
• Koscielny J, Jung F, Kiesewetter H, Haass A. Hemodilution. Springer-Verlag, New York 1992
   Google Scholar
• Forst H, Racenberg J, Schosser R, Messmer K. Right ventricular tissue PO2 in dogs; effect of hemodilution and acute right coronary artery occlusion. Res Exp Med 1987; 187: 159–74
   PubMedGoogle Scholar
• Spahn D R, Smith L R, McRae RL, Leone B J. Effects of acute isovolemic hemodilution and anesthesia on regional function in left ventricular myocardium with compromised coronary blood flow. Acta Anaesthesiol Scand 1992; 36: 628–36
   PubMed Web of Science ®Google Scholar
• Temper K K, Anderson S T. Perfluorochemical emulsion oxygen transport fluids. A clinical review. Ann Rev Med 1985; 30: 309–13
   Google Scholar
• Ohyanagy H, Toshima K, Sekita M. Clinical studies perfluorochemical whole blood substitutes: safety of Fluosol-DA (20%) in normal human volunteers. Clin Ther 1979; 2: 306–12
   Web of Science ®Google Scholar
• Mitsuno T, Ohyanagy H, Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA). Ann Surg 1982; 195: 60–9
   PubMed Web of Science ®Google Scholar
• Gould S A, Rosen A L, Sehgal L R. Fluosol-DA as a red-cell substitute in acute anemia. N Engl J Med 1986; 314: 1653–6
   PubMed Web of Science ®Google Scholar
• Elliott L A, Ledgerwood A M, Lucas C E. Role of Fluosol-DA 20% in prehospital resuscitation. Crit Care Med 1989; 17: 166–72
   PubMed Web of Science ®Google Scholar
• Spence R K, McCoy S, Costabile J. Fluosol-DA 20% in the treatment of severe anemia: randomized controlled study od 46 patients. Crit Care Med 1990; 18: 1227–30
   PubMed Web of Science ®Google Scholar
• Riess J D, Dalfors J L, Hanna G K. Development of high fluid concentrated and stable fluorocarbon emulsions for diagnostic and therapy. Biomat Art Cell and Immob Biotech 1992; 20: 839–42
   PubMed Web of Science ®Google Scholar
• Riess J G, Krafft M P. Elaboration of fluorocarbon emulsions with improved oxygen carrying capacities. Oxygen Transport to Tissue XVI, W Erdman, DF Bruley. Plenum Press, New York 1992
   Google Scholar
• Riess J G. Fluorocarbons-based blood substitutes: What progress. Int J Artif Org 1991; 14: 255–8
   PubMed Web of Science ®Google Scholar
• Dawidson I. Fluid resuscitation in shock: current controversies. Crit Care Med 1989; 17: 1078
   PubMed Web of Science ®Google Scholar
• Horton J, Landreneau R, Tyggle D. Cardiac response to fluid resuscitation from hemorrhagic shock. Surg Gynecol Obstet 1985; 160: 444
   PubMedGoogle Scholar
• Rayer A VS, Lambert G E, Fulton R L. Cardiac function during hemorrhagic shock and crystalloid resuscitation. J Surg Res 1978; 24: 35
   PubMed Web of Science ®Google Scholar
• Wang P, Chaudry I H. Crystalloid resuscitation restores but not maintain cardiac output following severe hemorrhage. J Surg Res 1991; 50: 163–9
   PubMed Web of Science ®Google Scholar
• Spahn D R, Smith R L, Veronee C D. Acute isovolemic hemodilution and blood transfusion; Effects on regional function and metabolism in myocardium with compromised coronary blood flow. J Thorac Cardiovasc Surg 1993; 105: 694–704
   PubMed Web of Science ®Google Scholar
• Allen J B, Allen F B. The minimal acceptable level of hemoglobin. Intern Anesth Clinics 1982; 20: 1–22
   PubMed Web of Science ®Google Scholar
• Mattrey R F, Hilpert P L, Long C D. Hemodynamic effects of intravenous lecithin-based perfluorocarbon emulsions in dogs. Crit Care med 1989; 17: 652–6
   PubMed Web of Science ®Google Scholar
• Keipert P E, Faithfull N S, Bradley J D. Oxygen delivery agumentation by low-dose perfluorochemical emulsion during profound normovolemic hemodilution. Oxygen Transport to Tissues XV, P Vaupel. Plenum Press, NY 1993
   Google Scholar